Nuclear hormone receptor coregulators in action: Diversity for shared tasks

Molecular Endocrinology

Volumn 14, Issue 3, 2000, Pages 329-347

  Robyr, Daniel ^a,c   Wolffe, Alan P ^b   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE DEACETYLASE; HORMONE RECEPTOR; PROTEIN P300; REPRESSOR PROTEIN; STEROID RECEPTOR COACTIVATOR 1; TRANSACTIVATOR PROTEIN;

CHROMATIN; GENE REPRESSION; PRIORITY JOURNAL; SHORT SURVEY; TRANSACTIVATION;

EID: 0034454583     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.3.0411     Document Type: Short Survey

References (146)

1. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
2. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
3. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity
4. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor)
5. The human estrogen receptor has two independent nonacidic transcriptional activation functions
6. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific
7. Steroid hormone receptors compete for factors that mediate their enhancer function
8. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription
9. Nuclear receptor coactivators and corepressors
10. Nuclear receptor coactivators
11. Co-activators and corepressors in the integration of transcriptional responses
12. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
13. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
14. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
15. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
16. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
17. Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator
18. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
19. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
20. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
21. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor-γ
22. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
23. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor co-activator
24. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1(AF1) and AF2 domains of steroid receptors
25. p300 is a component of an estrogen receptor coactivator complex
26. Role of CBP/p300 in nuclear receptor signalling
27. CREB-binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
28. Transcription - A growing coactivator network
29. Transcriptional control-versatile molecular glue
30. The p300/CBP family: Integrating signals with transcription factors and chromatin
31. The histone acetylase PCAF is a nuclear receptor coactivator
32. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
33. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
34. Transcription factor-specific requirements for co-activators and their acetyltransferase functions
35. Distinct steady-state nuclear receptor coregulators complexes exist in vivo
36. Nuclear receptors have distinct affinities for coactivators: Fluorescence resonance energy transfer
37. The transcriptional coactivators p300 and CBP are histone acetyltransferases
38. Steroid receptor coactivator-1 is a histone acetyltransferase
39. Linking histone acetylation to transcriptional regulation
40. The CBP co-activator is a histone acetyltransferase
41. Nuclear receptor coactivator ACTR is a novel histone acetyl-transferase and forms a multimeric activation complex with P/CAF and CBP/p300
42. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
43. Acetylation of general transcription factors by histone acetyltransferases
44. Regulation of activity of the transcription factor GATA-1 by acetylation
45. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases
46. 3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system
47. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
48. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion
49. Composite co-activator ARC mediates chromatin-directed transcriptional activation
50. A protein that interacts with members of the nuclear hormone receptor family: Identification and cDNA cloning
51. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors
52. Androstane metabolites bind to and deactivate the nuclear receptor CAR-β
53. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18
54. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
55. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
56. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II
57. cDNA cloning of a new putative ATPase subunit p45 of the human 26S proteasome, a homolog of yeast transcriptional factor Sug1p
58. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome
59. Interaction of proteins with transcriptionally active estrogen receptors
60. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
61. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites
62. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors
63. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex
64. Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement
65. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor
66. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor
67. p300/CREB binding protein-related protein p270 is a component of mammalian SWl/SNF complexes
68. Dopaminergic and ligand-independent activation of steroid hormone receptors
69. Activation of the liganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
70. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen responsive element
71. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate and insulin-like growth factor-I
72. Steroid hormone receptor phosphorylation: Is there a physiological role?
73. Phosphorylation of steroid hormone receptors
74. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region
75. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation
76. Estratiol receptor: Phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody
77. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
78. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1
79. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress
80. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4
81. CDK-independent activation of estrogen receptor by cyclin D1
82. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
83. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
84. Repression of transcription by nuclear receptors
85. The price of repression
86. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor
87. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist
88. Dual regulatory role for thyroid-hormone receptors allows control of retinoic- acid receptor activity
89. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product
90. A role for nucleosome assembly in both silencing and activation of the Xenopus TRβA gene by the thyroid hormone receptor
91. A transcriptional co-repressor that interacts with nuclear hormone receptors
92. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
93. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
94. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex
95. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release
96. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
97. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin-D3 receptors
98. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
99. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
100. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
101. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor
102. A nuclear hormone repector-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors
103. Inhibition of nuclear hormone receptor activity by calreticulin
104. Identification of a negative regulatory function for steroid receptors
105. Ssn6-Tupl is a general repressor of transcription in yeast
106. Repression domain of the yeast global repressor Tup1 interacts directly with histones H3 and H4
107. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
108. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
109. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
110. Transcriptional repression by the SMRT-mSin3 corepressor: Multiple interactions, multiple mechanisms, and a potential role for TFIIB
111. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
112. Role of the histone deacetylase complex in acute promyelocytic leukaemia
113. Interaction of human thyroid hormone receptor β with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone
114. II70
115. Stoichiometric and steric princliples governing repression by nuclear hormone receptors
116. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens
117. Histone-like TAFs within the PCAF histone acetylase complex
118. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
119. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
120. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2
121. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
122. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
123. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
124. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity
125. TRAM-l, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
126. A regulatory role for RIP140 in nuclear receptor activation
127. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2
128. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
129. ADA3: A gene identified by resistence to GAL4-VP16, with properties similar to and different from those of ADA2
130. A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro
131. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor
132. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
133. An adipogenic cofactor bound by the differentiation domain of PPARγ
134. Enhancement of human estrogen receptor activity by SPT6: A potential coactivator
135. Evidence that Spt6p controls chromatin structure by a direct interaction with histones
136. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors
137. Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae
138. Five SWl genes are required for expression of the HO gene in yeast
139. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
140. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription
141. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase
142. Two distinct nuclear receptor interacting domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivator
143. Identification of TRACs, a family of co-factors that associate with, and modulate the activity of nuclear hormone receptors
144. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor
145. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains
146. Molecular analysis of SSN6, a gene functionally related to the SNF1 protein kinase of Saccharomyces cerevisiae